SAT-LB113 Psychosocial Benefits of Using Basal-IQ® Predictive Low Glucose Suspend Technology in a Real-World Setting: Results From Pediatric Patients With Type 1 Diabetes

por Singh, Harsimran, Manning, Michelle, McElwee-Malloy, Molly, Habif, Steph
Publicado 2020

Virtual Pump Trainings for the t:slim X2 Insulin Pump With Control-IQ Advanced Hybrid Closed-Loop Technology: Real World Patient Experience

por Singh, Harsimran, Manning, Michelle, McElwee-Malloy, Molly, Habif, Steph
Publicado 2021

Application of the 4-Element Movement System Model to Sports Physical Therapy Practice and Education

por Zarzycki, Ryan, Malloy, Philip, Eckenrode, Brian J, Fagan, Jane, Malloy, Molly, Mangione, Kathleen K
Publicado 2022

Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology

por Pinsker, Jordan E., Müller, Lars, Constantin, Alexandra, Leas, Scott, Manning, Michelle, McElwee Malloy, Molly, Singh, Harsimran, Habif, Steph
Publicado 2021

Standardizing Clinically Meaningful Outcome Measures Beyond HbA(1c) for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American A...

por Agiostratidou, Gina, Anhalt, Henry, Ball, Dana, Blonde, Lawrence, Gourgari, Evgenia, Harriman, Karen N., Kowalski, Aaron J., Madden, Paul, McAuliffe-Fogarty, Alicia H., McElwee-Malloy, Molly, Peters, Anne, Raman, Sripriya, Reifschneider, Kent, Rubin, Karen, Weinzimer, Stuart A.
Publicado 2017